Navigation Links
Health Fidelity Announces Research Program to Support Advanced Use of Unstructured Clinical Data
Date:11/20/2013

PALO ALTO, Calif., Nov. 20, 2013 /PRNewswire/ -- Health Fidelity, a leading healthcare big data company, is making its cloud-based REVEAL product available for research use. REVEAL, Health Fidelity's natural language processing (NLP) platform, converts unstructured clinical notes into rich, fully structured and coded content in real-time. The product will support experienced researchers in leveraging the full clinical record rather than claims or discrete data alone. The cloud-based service will be offered through a one year research license for a $1,000 set up fee. A qualified principal investigator and a defined research protocol are required.

"The nation expects to see positive results from its enormous investment in healthcare information technology. The information is available and electronic. Healthcare organizations, industry and researchers must now come together to derive value from the full clinical record," said Dan Riskin, M.D., CEO and co-founder of Health Fidelity. "This research program is a small step toward delivering on a vision to leverage data to improve healthcare."

In recent years, the accuracy, usability, and breadth of commercial NLP technology has far surpassed open source systems based on heavy investment in research and development. As researchers aim to use the full clinical record to improve care, they will need advanced systems. REVEAL incorporates advanced clinical modeling defined and implemented under NSF and NIH funding and broad mapping to industry standard terminologies including ICD-9, ICD-10, SNOMED, RxNorm and LOINC. REVEAL also incorporates Columbia University's renowned MedLEE technology through exclusive license.

"REVEAL's advanced NLP capabilities generate a high-quality substrate for complex data mining projects to discover off-label drug use as well as drug related adverse events," said Dr. Nigam Shah, Assistant Professor at the Stanford Center for Biomedical Informatics Research. "We use REVEAL to create detailed feature maps of patients to ensure such adverse events do not occur."

George Hripsak, Chair of Department of Biomedical Informatics and Professor of Biomedical Informatics at Columbia University, states: "Columbia is delighted to see the power of MedLEE enhanced and combined with robust clinical modeling and a full terminology set. Working with the secure cloud service offers rapid implementation, scalability and a constantly improving product. It can be a great boon for the research community."

To apply for this research program, or for more information, visit healthfidelity.com/research.

About Health Fidelity
Health Fidelity, Inc., based in Palo Alto, Calif., is a healthcare big data company providing industry leading cloud-based healthcare natural language processing (NLP) and unstructured data management solutions.  Leveraging the longest standing clinical NLP technology with the most peer-reviewed literature and scientific citations, the company's REVEAL product is the world's most accurate, reliable and studied NLP technology in healthcare.  It enables application developers and healthcare organizations to utilize vast amounts of unstructured clinical data to improve quality and efficiency of the care delivery process.  Health Fidelity draws on its deep domain knowledge and understanding of medical language to unlock actionable information from this unstructured data.

Health Fidelity and REVEAL are trademarks of Health Fidelity, Inc. in the United States and/or other countries.

Media Contact:
Kate Ottavio
KNB Communications
203-504-8230
kottavio@knbpr.com


'/>"/>
SOURCE Health Fidelity
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Market Access and Pipeline Development – How Healthcare Modeling Can Make a Difference, a Pharmaceutical Market Strategy Webinar from Xtalks
2. Accuray to Present at Piper Jaffray 25th Annual Healthcare Conference
3. Bayer CropScience Charts Course For Cultivating Bee Health Solutions With Opening Of Clayton Bee Care Facility
4. Linguamatics Launches Healthcare Product Suite to Turn Unstructured Electronic Health Record Data into Actionable Patient Insights
5. Cardiums To Go Brands Acquired By Cell-nique And Healthy Brands Collective
6. International Collaboration Puts the Future of Healthcare IT on Display at the University City Science Center
7. “The New Health Conversation” to Premiere on PBS
8. Sciedu Press Support the New Open Access Policy of Canadian Institutes of Health Research
9. Vet-Stem, Inc. Proudly Announces Distribution Agreement with Animal Health International, Inc. for Regenerative Cell Therapies
10. Safety Recommendations Address Blood Clot Prevention for Pregnant Mothers: Physician-Patient Alliance for Health & Safety Presentation at National Perinatal Association Conference
11. AbbVie to Present at Jefferies 2013 Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... Noom Inc. , the leader ... offer fully Spanish behavior change programs that address ... prevention and healthy weight management programs  have ... interventions among Hispanic Americans who are at increased ... database, program-specific curriculum content and program features are ...
(Date:1/17/2017)... , Jan. 17, 2017  Northwell Health ... the advance of precision cancer research. ... largest health care provider, Northwell Health diagnoses ... Indivumed, GmbH is a Germany ... medical therapies. Together they will greatly expand cancer ...
(Date:1/17/2017)... Boston, MA (PRWEB) , ... January 17, 2017 ... ... of the completely re-engineered Drug Safety Technology Consortium™ (SafeTEC™), $3 million in investment ... be validating these new tools and assays, and their applicability in drug safety ...
(Date:1/17/2017)... , Jan. 17, 2017  Protagonist Therapeutics, ... that it has initiated a global Phase 2b ... oral peptide that targets alpha4beta7 integrin. The aim ... is to evaluate the safety/tolerability and efficacy of ... with moderate to severe active disease. ...
Breaking Biology Technology:
(Date:12/16/2016)... 2016 Research and Markets has announced the ... Forecast to 2021" report to their offering. ... The biometric vehicle access system ... CAGR of 14.06% from 2016 to 2021. The market is estimated ... reach 854.8 Million by 2021. The growth of the biometric vehicle ...
(Date:12/15/2016)... Calif. , Dec. 15, 2016   WaferGen ... publicly held genomics technology company, announced today that on ... Listing Qualifications Department of The Nasdaq Stock Market LLC ... closing bid price of WaferGen,s common stock had been ... Accordingly, WaferGen has regained compliance with Listing Rule 5550(a)(2) ...
(Date:12/15/2016)... , Dec. 15, 2016  There is much more ... or starting the engine. Continental will demonstrate the intelligence ... Las Vegas . Through the combination of the ... Entry) and biometric elements, the international technology company is ... personalization and authentication. "The integration of biometric ...
Breaking Biology News(10 mins):